Literature DB >> 33679803

Revisiting the Role of Natural Killer Cells in Non-Alcoholic Fatty Liver Disease.

María Luz Martínez-Chantar1,2, Teresa C Delgado1, Naiara Beraza3.   

Abstract

Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common form of chronic liver disease. The histological spectrum of NAFLD ranges from simple steatosis to chronic inflammation and liver fibrosis during Non-Alcoholic Steatohepatitis (NASH). The current view is that innate immune mechanisms represent a key element in supporting hepatic inflammation in NASH. Natural Killer (NK) cells are lymphoid cells and a component of the innate immune system known to be involved in NASH progression. Increasing evidence has shed light on the differential function of circulating and tissue-resident NK cells, as well as on the relevance of metabolism and the microenvironment in regulating their activity. Here, we revisit the complex role of NK cells as regulators of NASH progression as well as potential therapeutic approaches based on their modulation.
Copyright © 2021 Martínez-Chantar, Delgado and Beraza.

Entities:  

Keywords:  NAFLD; NASH; NK cells; metabolism; obesity

Mesh:

Year:  2021        PMID: 33679803      PMCID: PMC7930075          DOI: 10.3389/fimmu.2021.640869

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  76 in total

Review 1.  Pit cells as liver-associated natural killer cells: morphology and function.

Authors:  Kazuki Nakatani; Kenji Kaneda; Shuichi Seki; Yuji Nakajima
Journal:  Med Electron Microsc       Date:  2004-03

2.  Adipose-Resident Group 1 Innate Lymphoid Cells Promote Obesity-Associated Insulin Resistance.

Authors:  Timothy E O'Sullivan; Moritz Rapp; Xiying Fan; Orr-El Weizman; Priya Bhardwaj; Nicholas M Adams; Thierry Walzer; Andrew J Dannenberg; Joseph C Sun
Journal:  Immunity       Date:  2016-08-02       Impact factor: 31.745

3.  Metabolic reprogramming of natural killer cells in obesity limits antitumor responses.

Authors:  Xavier Michelet; Lydia Dyck; Andrew Hogan; Roisin M Loftus; Danielle Duquette; Kevin Wei; Semir Beyaz; Ali Tavakkoli; Cathriona Foley; Raymond Donnelly; Cliona O'Farrelly; Mathilde Raverdeau; Ashley Vernon; William Pettee; Donal O'Shea; Barbara S Nikolajczyk; Kingston H G Mills; Michael B Brenner; David Finlay; Lydia Lynch
Journal:  Nat Immunol       Date:  2018-11-12       Impact factor: 25.606

4.  Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells.

Authors:  Sinéad E Keating; Vanessa Zaiatz-Bittencourt; Roisín M Loftus; Ciara Keane; Kiva Brennan; David K Finlay; Clair M Gardiner
Journal:  J Immunol       Date:  2016-02-12       Impact factor: 5.422

5.  Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells.

Authors:  R B Herberman; M E Nunn; H T Holden; D H Lavrin
Journal:  Int J Cancer       Date:  1975-08-15       Impact factor: 7.396

6.  TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess.

Authors:  Leila Idrissova; Harmeet Malhi; Nathan W Werneburg; Nathan K LeBrasseur; Steven F Bronk; Christian Fingas; Tamar Tchkonia; Tamar Pirtskhalava; Thomas A White; Michael B Stout; Petra Hirsova; Anuradha Krishnan; Christian Liedtke; Christian Trautwein; Niklas Finnberg; Wafik S El-Deiry; James L Kirkland; Gregory J Gores
Journal:  J Hepatol       Date:  2014-11-28       Impact factor: 25.083

7.  IL-6/Stat3-Dependent Induction of a Distinct, Obesity-Associated NK Cell Subpopulation Deteriorates Energy and Glucose Homeostasis.

Authors:  Sebastian Theurich; Eva Tsaousidou; Ruth Hanssen; Adelheid M Lempradl; Jan Mauer; Katharina Timper; Katharina Schilbach; Kat Folz-Donahue; Christian Heilinger; Veronika Sexl; John Andrew Pospisilik; F Thomas Wunderlich; Jens C Brüning
Journal:  Cell Metab       Date:  2017-07-05       Impact factor: 27.287

Review 8.  Formation and function of the lytic NK-cell immunological synapse.

Authors:  Jordan S Orange
Journal:  Nat Rev Immunol       Date:  2008-09       Impact factor: 53.106

9.  Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners.

Authors:  Svetlana Radaeva; Rui Sun; Barbara Jaruga; Van T Nguyen; Zhigang Tian; Bin Gao
Journal:  Gastroenterology       Date:  2006-02       Impact factor: 22.682

Review 10.  Inflammation and metabolism in tissue repair and regeneration.

Authors:  Sabine A Eming; Thomas A Wynn; Paul Martin
Journal:  Science       Date:  2017-06-08       Impact factor: 47.728

View more
  10 in total

Review 1.  Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity.

Authors:  Herbert Tilg; Timon E Adolph; Michael Dudek; Percy Knolle
Journal:  Nat Metab       Date:  2021-12-20

Review 2.  The antifibrotic role of natural killer cells in liver fibrosis.

Authors:  Yuan Wei; Wang Bingyu; Yang Lei; Yuan Xingxing
Journal:  Exp Biol Med (Maywood)       Date:  2022-04-27

Review 3.  Hepatic Stellate Cell-Immune Interactions in NASH.

Authors:  James K Carter; Scott L Friedman
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

4.  Type 1 Innate Lymphoid Cells Are Proinflammatory Effector Cells in Ischemia-Reperfusion Injury of Steatotic Livers.

Authors:  Jiman Kang; Jedson R Liggett; Digvijay Patil; Suman Ranjit; Katrina Loh; Anju Duttargi; Yuki Cui; Kesha Oza; Brett S Frank; DongHyang Kwon; Bhaskar Kallakury; Simon C Robson; Thomas M Fishbein; Wanxing Cui; Khalid Khan; Alexander Kroemer
Journal:  Front Immunol       Date:  2022-06-27       Impact factor: 8.786

5.  The Role of Natural Killer Cells in Nonalcoholic Steatohepatitis: An Ongoing Debate.

Authors:  Xiaojun Jiang; Espen Melum
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2021-11-02

Review 6.  T Cell Subsets and Natural Killer Cells in the Pathogenesis of Nonalcoholic Fatty Liver Disease.

Authors:  Yoseph Asmelash Gebru; Haripriya Gupta; Hyeong Seop Kim; Jung A Eom; Goo Hyun Kwon; Eunju Park; Jin-Ju Jeong; Sung-Min Won; Satya Priya Sharma; Raja Ganesan; Dong Joon Kim; Ki Tae Suk
Journal:  Int J Mol Sci       Date:  2021-11-11       Impact factor: 5.923

7.  Immunological risk factors for nonalcoholic fatty liver disease in patients with psoriatic arthritis: New predictive nomograms and natural killer cells.

Authors:  Baochen Li; Rui Su; Huanhuan Yan; Juanjuan Liu; Chong Gao; Xiaofeng Li; Caihong Wang
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

8.  Chemerin Overexpression in the Liver Protects against Inflammation in Experimental Non-Alcoholic Steatohepatitis.

Authors:  Rebekka Pohl; Susanne Feder; Elisabeth M Haberl; Lisa Rein-Fischboeck; Thomas S Weiss; Marlen Spirk; Astrid Bruckmann; Nichole McMullen; Christopher J Sinal; Christa Buechler
Journal:  Biomedicines       Date:  2022-01-07

Review 9.  Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease.

Authors:  Daryl Ramai; Antonio Facciorusso; Erika Vigandt; Bryan Schaf; Waleed Saadedeen; Aditya Chauhan; Sara di Nunzio; Aashni Shah; Luca Giacomelli; Rodolfo Sacco
Journal:  Cells       Date:  2021-12-02       Impact factor: 6.600

Review 10.  Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System.

Authors:  Pietro Torre; Benedetta Maria Motta; Roberta Sciorio; Mario Masarone; Marcello Persico
Journal:  Front Med (Lausanne)       Date:  2021-12-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.